A combination of artemisinin, moxidectin, and doxorubicin drugs can selectively and efficiently induce apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo [PDF]
Viviana Soto-Mercado +3 more
openalex +1 more source
Enhancer‐dependent gene regulation in space, time, and malignancies
Abstract Control of cell‐type‐specific gene activation requires the coordinated activity of distal regulatory elements, including enhancers, whose inputs must be temporally integrated. Dysregulation of this regulatory capacity, such as aberrant usage of enhancers, can result in malignant transformation of cells.
Belinda Blum +2 more
wiley +1 more source
Global burden of acute lymphoblastic leukemia following the COVID-19 pandemic. [PDF]
Fan H +6 more
europepmc +1 more source
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner +7 more
wiley +1 more source
Combination of targeted pharmacotherapy and immunotherapy with anti-CD19 CAR NK cells in acute lymphoblastic leukemia. [PDF]
Kirchhoff H +10 more
europepmc +1 more source
Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia
Emily S. Tonorezos +9 more
openalex +1 more source
ABSTRACT Survival outcomes for adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) have improved with modern frontline therapies and minimal residual disease (MRD)‐guided strategies. As a result, allogeneic hematopoietic cell transplantation (HCT) is increasingly deferred in first remission (CR1) and used in the relapsed setting.
Oren Pasvolsky +24 more
wiley +1 more source
Management of relapsed acute lymphoblastic leukemia in a patient with down syndrome: A case report. [PDF]
Almatar E, Alsharidah S, Hashem OA.
europepmc +1 more source
ABSTRACT Asparaginase is an integral component of therapy for pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma. The success of asparaginase‐containing regimens has led to trials of pediatric/pediatric‐inspired regimens incorporating asparaginase for treating adolescent and young adult (AYA) and adult populations with acute ...
Ibrahim Aldoss +7 more
wiley +1 more source
Cortical morphological alterations and structural covariant network topology changes in children with acute lymphoblastic leukemia. [PDF]
Wei K +5 more
europepmc +1 more source

